|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2007
Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators
Dept of Internal Medicine, University Hospital Basel, Basel, Switzerland.
CORRESPONDENCE: B. Müller, Dept of Internal Medicine, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland. Fax: 41 612655100. E-mail: happy.mueller{at}unibas.ch
Keywords: Antibiotics, hormones, pneumonia, sepsis
Received: December 20, 2006
Accepted March 15, 2007
Used appropriately, biomarkers improve the assessment of respiratory tract infections and sepsis. Most prominently, circulating procalcitonin levels increase by a factor of several tens of thousands during sepsis. Using a sensitive assay, procalcitonin safely and markedly reduces antibiotic usage in respiratory tract infections and nonbacterial meningitis. Procalcitonin is the protopye of hormokine mediators. The term "hormokine" encompasses the cytokine-like behaviour of hormones during inflammation and infections. The concept is based on a ubiquitous expression of calcitonin peptides during sepsis. Adrenomedullin, another member of the calcitonin peptide superfamily, was shown to complement and improve the current prognostic assessment in lower respiratory tract infections. Other peptides share some features of hormokines, e.g. natriuretic peptide and copeptin. Hormokines are not only biomarkers of infection but are also pivotal inflammatory mediators. Like all mediators, their role during systemic infections is basically beneficial, possibly to combat invading microbes. However, at increased levels they can become harmful for their host. Multiple mechanisms of action were proposed. In several animal models the modulation and neutralisation of hormokines during infection was shown to improve survival, and thus might open new treatment options for severe infections, especially of the respiratory tract.
This article has been cited by other articles:
|
|
 |
|
  J. M. Porcel, M. Vives, G. Cao, S. Bielsa, A. Ruiz-Gonzalez, A. Martinez-Iribarren, and A. Esquerda Biomarkers of infection for the differential diagnosis of pleural effusions Eur. Respir. J., December 1, 2009; 34(6): 1383 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Menendez, R Martinez, S Reyes, J Mensa, E Polverino, X Filella, C Esquinas, A Martinez, P Ramirez, and A Torres Stability in community-acquired pneumonia: one step forward with markers? Thorax, November 1, 2009; 64(11): 987 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S Brown Biomarkers and community-acquired pneumonia Thorax, July 1, 2009; 64(7): 556 - 558. [Full Text] [PDF]
|
|
|
|
|
|
R Menendez, R Martinez, S Reyes, J Mensa, X Filella, M A Marcos, A Martinez, C Esquinas, P Ramirez, and A Torres Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia Thorax, July 1, 2009; 64(7): 587 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Blasi, R. Cosentini, G. B. Migliori, and W. Boersma Steps forward in LRTI and tuberculosis: update from the ERS Respiratory Infections Assembly Eur. Respir. J., June 1, 2009; 33(6): 1448 - 1453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W L Cals, C. C Butler, R. M Hopstaken, K. Hood, and G.-J. Dinant Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial BMJ, May 5, 2009; 338(may05_1): b1374 - b1374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ewig and T. Welte CRB-65 for the assessment of pneumonia severity: who could ask for more? Thorax, August 1, 2008; 63(8): 665 - 666. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |